4//SEC Filing
Winters Chad 4
Accession 0001127602-23-028965
CIK 0000105770other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 7:33 PM ET
Size
11.3 KB
Accession
0001127602-23-028965
Insider Transaction Report
Form 4
Winters Chad
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2023-12-01$349.00/sh−1,013$353,541→ 1,269.698 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-12-01−456→ 0 totalExercise: $143.43From: 2020-10-29Exp: 2029-10-29→ Stock Options (Right to Buy) (456 underlying) - Exercise/Conversion
Common Stock
2023-12-01$143.43/sh+456$65,404→ 1,941.698 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-12-01−341→ 1,571 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Stock Options (Right to Buy) (341 underlying) - Exercise/Conversion
Common Stock
2023-12-01$173.22/sh+341$59,068→ 2,282.698 total
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001811424
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 7:33 PM ET
- Size
- 11.3 KB